Biodegradable Stents Market, by Product Type (Coronary Stents and Peripheral Stents), by Material Type (Polymer-based Stents and Metallic Stents), by End User (Hospitals, Specialty Clinics and Ambulatory Surgical Centers) and by Region - Global Forecast to 2026

  • Published On : Jul 2018 |
  • Pages : 150 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Biodegradable Stents Market Insights – Say No to Infinite Stay of Foreign Material

Stents are metal scaffolds used for opening the blocked vessel to optimize the flow of biliary fluid or blood through the vessel. Biodegradable stents also called as bioresorbable stents are type of stents made from special biodegradable material such as polymers and metal, eliminating the stents removal and side-effects of conventional stents. Biodegradable polymers evaluated for stent manufacture are polylactic acid (PLA), poly-DL-lactic acid (PDLLA), poly-L-lactic acid (PLLA), poly-DL-lactide-co-glycolide (PDLGA), poly-lactic-co glycolide (PLGA), polycaprolactone (PCL), polylactic acid/polycaprolactone (PLA/PCL), whereas biodegradable metal are made up of magnesium, stainless steel, and cobalt chromium. Biodegradable material hydrolyze in presence of water and convert into simple biological compounds.

The global biodegradable stents market size is estimated to be valued at US$ 278.6 million in 2018, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).

Figure 1. Global Biodegradable Stents Market Share, By Product Type

Biodegradable Stents  | Coherent Market Insights 

Source: Coherent Market Insights Analysis (2018)

Increasing risk of cardiovascular disease is driving the biodegradable stents market growth

High risk of developing cardiovascular disease is expected to fuel the biodegradable stents market growth over the forecast period. For instance, according to American Heart Association, cardiovascular disease is a leading cause of death worldwide, owning for more than 17.3 million deaths per year in 2013, comprising around 31% and number is expected to grow to more than 23.6 million by 2030.

Moreover, as per American Heart Association’s Heart Disease and Stroke Statistics 2017, 39.7% of American adults suffer from high cholesterol, which is projecting them towards higher

risk of arterial blockage. Furthermore, sedentary lifestyle and increasing proportion of obesity and geriatric population is also expected to drive growth of the biodegradable stents market.

Biodegradable stents are gaining traction and adoption attributing to drawbacks of bare metal stents. For instance, bare metal stents are reported to cause hypersensitivity reaction and issues such as late drug eluting stents thrombosis. However, high cost of the biodegradable stents is the major factor hindering the market growth.

Biodegradable stents market regional outlook - Asia Pacific to be the fastest growing market

The regional biodegradable stents market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. Europe holds dominant position in biodegradable stents market, owing to presence of large number of approved products in the region. On the other hand, the market in North America is expected to experience growth gradually once there approved products sail through successfully in the market. Moreover, there is increasing prevalence of cardiac blockage due to sedentary lifestyle in the region. For instance, according to Center for Disease Control and Prevention (CDC), the three major factor leading to heart disease are high blood pressure, high cholesterol, and smoking, which has prevalence of 47% of the American population attributing to the disease prone population. However, biodegradable stents market in Asia Pacific is expected to witness significant growth, owing increasing medical tourism and increasing adoption of biodegradable stents. Moreover, emerging economies such as India and China offers wide opportunity for the market players, which is fuelling growth of the regional biodegradable stents market.

Figure 2. Global Biodegradable Stents Market, By Region

Biodegradable Stents  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

The key players dominating the global biodegradable stents market

Major players operating in biodegradable stents market include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., and Arterial Remodeling Technologies SA.

The global biodegradable stents market growth is also driven by the inorganic strategies of the market players. For instance, in 2015, Cardinal Health acquired Cordis, a subsidiary of Johnson & Johnson, for US$ 1.9 billion. The acquisition will roll on the Cordis’s S.M.A.R.T., vascular stents system.

Biodegradable stents are medical devices made up of bio-absorbable material such as polymer or metal used to achieve normal flow of blood or other bloodily fluids in case of clogged or narrowed vessels. The report delivers concise and clear in-depth analysis of market size and market growth under the scope product type, material type, and end users. Furthermore, report tracks the recent product launches, and trends driving the biodegradable stents market. However, report also focuses on the factors which are hindering the global biodegradable stents market growth.

Market Dynamics

Factors such as increasing product launches with biodegradable material or technologically advanced form such as completely degradable stents and increasing incidences of cardiac coronary artery disease are driving the biodegradable stents market growth. For instance, in 2016, Biotronik SE & Co. received CE approval for Magmaris, which is first clinically-proven magnesium scaffold based bioresorbable stents for the treatment of coronary artery disease. Moreover, the pipeline product are aiding to the biodegradable stents market growth over the forecast period. For instance, Scitech Produtos Medicos Ltda is conducting clinical trials for Inspiron stents and biomatrix flex stents for the coronary artery disease, which as on April 2018, was in phase 4 trial. However, the drawbacks associated with polymer such as expansion and recoiling of stents, are expected to restrain the biodegradable stents market growth.

Key features of the study:

  • This report provides in-depth analysis of the biodegradable stents market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biodegradable stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
  • The global biodegradable stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of biodegradable stents, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the biodegradable stents market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Biodegradable Stents Market, By Product Type:
    • Coronary Stents
    • Peripheral Stents
  • Global Biodegradable Stents Market, By Material Type:
    • Polymer-based Stents
    • Metallic Stents
  • Global Biodegradable Stents Market, By End Users:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Global Biodegradable Stents Market, By Region:
    • North America
      • By Product Type:
        • Coronary Stents
        • Peripheral Stents
      • By Material Type:
        • Polymer-based Stents
        • Metallic Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Coronary Stents
        • Peripheral Stents
      • By Material Type:
        • Polymer-based Stents
        • Metallic Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Coronary Stents
        • Peripheral Stents
      • By Material Type:
        • Polymer-based Stents
        • Metallic Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Germany
        • U.K.
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Coronary Stents
        • Peripheral Stents
      • By Material Type:
        • Polymer-based Stents
        • Metallic Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Coronary Stents
        • Peripheral Stents
      • By Material Type:
        • Polymer-based Stents
        • Metallic Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Coronary Stents
        • Peripheral Stents
      • By Material Type:
        • Polymer-based Stents
        • Metallic Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Market Strategies
    • Abbott
    • Kyoto Medical Planning Co., Ltd.
    • QualiMed
    • Elixir Medical Corporation
    • ENDOCOR GmbH
    • BIOTRONIK SE & Co. KG
    • Amaranth Medical, Inc.
    • Arterial Remodeling Technologies SA

*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Disease Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Industry Trends
    • Recent Approvals
    • Regulatory Scenario
    • Epidemiology
    • PEST Analysis
  4. Global Biodegradable Stents Market, By Product Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Coronary Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Peripheral Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Biodegradable Stents Market, By Material Type, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Polymer-based Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Metallic Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Biodegradable Stents Market, By End User, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Biodegradable Stents Market, By Region, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Boston Scientific Corporation*
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Kyoto Medical Planning Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • QualiMed
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Elixir Medical Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • ENDOCOR GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • BIOTRONIK SE & Co. KG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Amaranth Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Arterial Remodeling Technologies SA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 32 market data tables and 30 figures on “Biodegradable Stents Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.